M. Maccarrone et al., Activation of 5-lipoxygenase and related cell membrane lipoperoxidation inhemodialysis patients, J AM S NEPH, 10(9), 1999, pp. 1991-1996
Lipid peroxidation was shown at the membrane level in peripheral blood cell
s of patients hemodialyzed on cuprophan dialyzers, and was mainly attributa
ble to the generation of conjugated hydroperoxides in the lipid bilayer. Th
e oxidative index (i.e., the A(234/205) ratio) of membrane lipids was 3.2-f
old higher in hemodialysis patients than in healthy control subjects, and a
lso the level of leukotriene B-4 was significantly increased (up to 1.7-fol
d over control). Both membrane peroxidation and release of leukotriene B-4
were linked to upregulation of 5-lipoxygenase activity (up to 2.4-fold over
control) and expression at the protein level (up to 1.9-fold). Vitamin E,
the most important lipophilic antioxidant, prevented both membrane peroxida
tion and release of leukotriene B-4 by inhibiting 5-lipoxygenase activity w
ithout affecting enzyme expression. Similar results were observed in patien
ts hemodialyzed on polymethylmetacrylate membranes, but in this case the ac
tivation of 5-lipoxygenase was less pronounced. The use of a purified 5-lip
oxygenase demonstrated that vitamin E was a reversible inhibitor of enzyme
activity (IC50 = 35 +/- 4 mu M), further characterized as noncompetitive (K
i = 30 +/- 3 mu M). Taken together, the results reported here shed some lig
ht on the mechanism responsible for the oxidative damage in hemodialysis. M
oreover, the beneficial effect of vitamin E described here may have relevan
ce for the therapy of patients with kidney disease.